Literature DB >> 20555090

Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use.

D Schrijvers1, H De Samblanx, F Roila.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555090     DOI: 10.1093/annonc/mdq202

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  39 in total

Review 1.  What do prescribers think of biosimilars?

Authors:  M S Aapro
Journal:  Target Oncol       Date:  2012-01-19       Impact factor: 4.493

2.  Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer.

Authors:  Matti Aapro; Paul Cornes; Diana Sun; Ivo Abraham
Journal:  Ther Adv Med Oncol       Date:  2012-05       Impact factor: 8.168

Review 3.  Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.

Authors:  F Lebrun; J Klastersky; D Levacq; Y Wissam; M Paesmans
Journal:  Support Care Cancer       Date:  2017-04-07       Impact factor: 3.603

Review 4.  The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  J Mol Med (Berl)       Date:  2013-09-21       Impact factor: 4.599

5.  Results from the LIDO anemia survey: adherence to EORTC guidelines in cancer patients in France.

Authors:  Vincent Launay-Vacher; Nicolas Janus; Gilbert Deray; Florian Scotté
Journal:  Support Care Cancer       Date:  2016-03-15       Impact factor: 3.603

6.  Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000-2013.

Authors:  Lanfang Xu; Hairong Xu; Kimberly Cannavale; Olivia Sattayapiwat; Roberto Rodriguez; John H Page; Chun Chao
Journal:  Support Care Cancer       Date:  2016-02-12       Impact factor: 3.603

7.  The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Luciana Tanca; Maria Cristina Cherchi; Carlo Floris; Itaru Omoto; Antonio Barracca; Tomas Ganz
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

8.  Single measurement of hemoglobin predicts outcome of HCC patients.

Authors:  Fabian Finkelmeier; Dominik Bettinger; Verena Köberle; Michael Schultheiß; Stefan Zeuzem; Bernd Kronenberger; Albrecht Piiper; Oliver Waidmann
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

9.  Management of anemia and iron deficiency in a cancer center in France.

Authors:  Florence Laï-Tiong; Cloé Brami; Olivier Dubroeucq; Florian Scotté; Hervé Curé; Nicolas Jovenin
Journal:  Support Care Cancer       Date:  2015-08-08       Impact factor: 3.603

10.  Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.

Authors:  Antonios Douros; Kathrin Jobski; Bianca Kollhorst; Tania Schink; Edeltraut Garbe
Journal:  Br J Clin Pharmacol       Date:  2016-06-22       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.